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LAT1 Protein Content Increases
Following 12 Weeks of Resistance
Exercise Training in Human Skeletal
Muscle
Paul A. Roberson 1†‡ , C. Brooks Mobley 2 , Matthew A. Romero 1‡ , Cody T. Haun 1‡ ,
Shelby C. Osburn 1 , Petey W. Mumford 1‡ , Christopher G. Vann 1 , Rory A. Greer 1‡ ,
Arny A. Ferrando 3 and Michael D. Roberts 1*†
1

School of Kinesiology, Auburn University, Auburn, AL, United States, 2 Department of Physiology, College of Medicine,
University of Kentucky, Lexington, KY, United States, 3 Department of Geriatrics, Donald W. Reynolds Institute on Aging,
University of Arkansas for Medical Sciences, Little Rock, AK, United States

Introduction: Amino acid transporters are essential for cellular amino acid transport
and promoting protein synthesis. While previous literature has demonstrated the
association of amino acid transporters and protein synthesis following acute resistance
exercise and amino acid supplementation, the chronic effect of resistance exercise and
supplementation on amino acid transporters is unknown. The purpose herein was to
determine if amino acid transporters and amino acid metabolic enzymes were related to
skeletal muscle hypertrophy following resistance exercise training with different nutritional
supplementation strategies.
Methods: 43 college-aged males were separated into a maltodextrin placebo (PLA,
n = 12), leucine (LEU, n = 14), or whey protein concentrate (WPC, n = 17) group and
underwent 12 weeks of total-body resistance exercise training. Each group’s supplement
was standardized for total energy and fat, and LEU and WPC supplements were
standardized for total leucine (6 g/d). Skeletal muscle biopsies were obtained prior to
training and ∼72 h following each subject’s last training session.
Results: All groups increased type I and II fiber cross-sectional area (fCSA) following
training (p < 0.050). LAT1 protein increased following training (p < 0.001) and increased
more in PLA than LEU and WPC (p < 0.050). BCKDHα protein increased and ATF4
protein decreased following training (p < 0.001). Immunohistochemistry indicated total
LAT1/fiber, but not membrane LAT1/fiber, increased with training (p = 0.003). Utilizing all
groups, the change in ATF4 protein, but no other marker, trended to correlate with the
change in fCSA (r = 0.314; p = 0.055); however, when regression analysis was used to
delineate groups, the change in ATF4 protein best predicted the change in fCSA only in
LEU (r 2 = 0.322; p = 0.043). In C2C12 myoblasts, LAT1 protein overexpression caused
a paradoxical decrease in protein synthesis levels (p = 0.002) and decrease in BCKDHα
protein (p = 0.001).
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Conclusions: Amino acid transporters and metabolic enzymes are affected by
resistance exercise training, but do not appear to dictate muscle fiber hypertrophy. In
fact, overexpression of LAT1 in vitro decreased protein synthesis.
Keywords: amino acid metabolism, ATF4, protein supplementation, protein synthesis, BCKDH

INTRODUCTION

altered following exercise and/or nutrition chronic interventions
in human skeletal muscle.
Metabolism of branched-chain amino acids (BCAAs) also
plays a role in regulating protein synthesis. Notably, BCAA
catabolism begins in the mitochondria with the reversible
transamination of BCAAs by the metabolic enzyme branchedchain aminotransferase 2 (BCAT2) which produces branchedchain α-keto acids (BCKAs). BCKAs then undergo irreversible
oxidative decarboxylation by the branched-chain α-keto acid
dehydrogenase (BCKDH) complex. Importantly, the BCKDH
reaction is the rate-limiting enzyme and the commitment step
for BCAA metabolism. Regulation of the BCKDH complex is
tightly controlled by BCKDH kinase and BCKDH phosphatase.
BCKDH kinase phosphorylates the BCKDH complex on the
alpha/E1 component (BCKDHα) to inactivate it (25), while
BCKDH phosphatase dephosphorylates the BCKDH complex to
activate it, resulting in BCAA catabolism. The literature involving
the BCKDH complex with regard to humans, exercise, and
nutrition is scarce and discrepant. For instance, in rat skeletal
muscle it was reported that endurance training decreases skeletal
muscle BCKDH kinase protein content (26); however, in human
skeletal muscle, endurance training increases BCKDH kinase
protein content (27). Interestingly, exercise increases activation
of the complex to promote oxidation of BCAAs (28, 29).
Furthermore, BCKDH kinase is inactivated by protein or amino
acid supplementation promoting increased BCAA oxidation
(29). Research on the complex involving exercise has utilized
various forms of endurance exercise; however, the effects of
resistance exercise and nutrition on regulation of the complex
is unknown.
Resistance exercise independently, and with essential amino
acid or protein supplementation, has been shown to improve
skeletal muscle size, function, and quality in both young and
old humans (30–36). Furthermore, acute resistance exercise has
been shown to independently increase the mRNA expression and
protein content of amino acid transporters (19, 37). Researchers
have also demonstrated that amino acid transporter protein
content is further improved when a supplement containing
amino acids is ingested following exercise (18, 21, 38). Studies
in this area, however, have only examined the acute response
following resistance exercise, and the chronic response following
resistance exercise training has yet to be determined. Therefore,
the purpose of this study was to determine how skeletal
muscle ATF4 protein levels, amino acid transporters, and
metabolic enzymes involved with BCAAs catabolism are altered
following resistance exercise training with different nutritional
supplementation strategies, and if these changes are related to
skeletal muscle fiber hypertrophy. Furthermore, based on these

Skeletal muscle possesses the unique ability to adapt to metabolic
and loading demands. For example, disuse and physical inactivity
contribute to muscle atrophy (1, 2), while both aerobic and
resistance training can improve skeletal muscle quality and
promote hypertrophy (3, 4). To enhance exercise training
adaptations it has been suggested to ingest upwards of 1.6–
2.0 g/kg of dietary protein (5–7). While it remains to be fully
determined how greater consumption of amino acids promotes
muscle growth, essential amino acids (and leucine in particular)
are capable of simulating increases in muscle protein synthesis
suggesting a positive role for amino acids in promoting skeletal
muscle hypertrophy (8–10).
In skeletal muscle, amino acid transporters function by
transporting amino acids that are unique to specific transporters
from the interstitial fluid to the sarcoplasm of muscle fibers. For
instance, the L-type amino acid transporter 1 (LAT1) primarily
transports leucine into the sarcoplasm while co-transporting
glutamine out of the cell, whereas the sodium-coupled neutral
amino acid transporter 2 (SNAT2) co-transports both sodium
and glutamine into the sarcoplasm. These two transport proteins
work in tandem such that SNAT2 brings in glutamine for LAT1
to pump back out of the cell while concomitantly transporting
leucine into the cell. Leucine has been deemed as an essential
regulator of protein synthesis (11), and independently increases
protein synthesis through activation of the mechanistic target of
rapamycin in complex 1 (mTORC1) (12–14). Another important
amino acid transporter, proton-assisted amino acid transporter
1 (PAT1), lies within the lysosomal membrane and is speculated
to be important for sensing lysosomal amino acids as well as
signaling mTORC1 to the lysosomal membrane to promote the
complex’s activation (15). These intricate mechanisms illustrate
that amino acid transporters are likely critical for facilitating
skeletal muscle hypertrophy.
The previously mentioned amino acid transporters share a
common transcription factor known as activating transcription
factor 4 (ATF4) (16, 17). It could be posited that an increase
in ATF4 protein would induce the transcription of the
aforementioned amino acid transporters and, thereafter, promote
an increase in protein synthesis by increasing intracellular
amino acid concentrations. Indeed, several acute human studies
have demonstrated that increases in protein synthesis occur in
conjunction with an increase in ATF4 protein levels (18–21).
However, recent literature suggests that inhibition or knockdown
of ATF4 protein promotes protein synthesis, improves muscle
strength and quality, and increases muscle fiber diameter in
mice (22–24). It has yet to be determined how ATF4 protein is
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in vivo findings, in vitro experiments were performed to elucidate
potential mechanisms.

TABLE 1 | Macronutrient information per serving.

METHODS

Energy (kcal)

204

200

184

Total carbohydrate (g)

44.4

43.1

12.0

PLA

Ethical Approval and Participant Screening
Prior to commencing this study, this protocol was reviewed and
approved by the Auburn University Institutional Review Board
and was in compliance with the Helsinki Declaration (approved
protocol #: 15-320 MR 1508). Participants read and signed
an informed consent prior to participation. Males that were
apparently healthy, free of medical or orthopedic conditions,
19–23 years old, and unaccustomed to resistance training were
recruited for participation. Participants stated they had not
resistance trained within 6 months, used anabolic steroids,
consumed dietary protein in excess of 2.0 g/kg/day regularly, or
been consuming dietary supplements.

WPC

Dietary fiber (g)

1.6

1.8

1.8

Sugars (g)

6.0

5.1

5.9

Protein (g)

0.4

2.3

26.3

Total fat (g)

2.8

2.0

3.5

Leucine (mg)

15

2,871

2,794

Bold lettering highlights differences between supplementation groups.

Sciences; Hatfield, PA, USA), slowly frozen in liquid nitrogencooled isopentane, and then stored at −80◦ C until staining
procedures. Leftover tissue following IHC partitioning was flashfrozen in liquid nitrogen and stored at −80◦ C until further
analyses. PRE and POST muscle biopsies were taken from the
same leg at least 5 cm apart.

Experimental Design
This study is a follow-up analysis from a prior study, and
readers are encouraged to read Mobley et al. (39) for complete
methods including participant assignment to supplement groups
according to whole-body lean tissue mass (assessed by dualenergy x-ray absorptiometry). Importantly, certain groups from
that investigation were omitted (i.e., SOY and WPH), given that
we felt the included groups (i.e., PLA, LEU, and WPC) would
better delineate supplementation-related effects related to leucine
and all amino acids (further described in “Supplementation and
Dietary Intake”). Briefly, for baseline testing (PRE), participants
refrained from physical activity for 96 h, reported to the
laboratory hydrated (urine specific gravity <1.020), and 4 h
fasted. Participants were then analyzed for body composition
via DEXA (General Electric Lunar Prodigy enCORE, version
10.50086; Madison, WI, USA) and donated a skeletal muscle
biopsy sample from the vastus lateralis. Two to three days
following PRE, initial strength testing was conducted, and these
baseline values were used for program prescription. Upon
PRE completion, supplementation including placebo (PLA),
leucine (LEU), and whey protein concentrate (WPC) was
assigned to participants. Participants were instructed to consume
supplements twice daily throughout the resistance exercise
training protocol, which was completed 3x/week for 12 weeks.
Approximately 72 h following each participant’s last training
session, the participant arrived similar to PRE conditions,
underwent DEXA analysis, and donated a second skeletal muscle
biopsy sample (POST).

Supplementation and Dietary Intake
Participants were counterbalanced into one of five groups
although as previously mentioned only three groups were
utilized: placebo (PLA), leucine (LEU), and whey protein
concentrate (WPC). Group counterbalancing was based
on DEXA lean body mass. Groups differed based on the
supplementation provided, and the nutritional breakdown for
each supplement is provided in Table 1. Notably, each PLA
serving contained 44.4 g of carbohydrate with little leucine and
protein, each LEU serving contained 43.1 g of carbohydrate
with 2,871 mg of leucine and little protein, and WPC serving
contained little carbohydrate with 2,794 mg of leucine and
26.3 g of protein. Each supplement was formulated to contain a
similar amount of total energy (kcal) and fat (g) and was blinded
to laboratory personnel and participants. Supplements were
similar in appearance, taste, texture, and packaging; however,
supplement packages only contained a serial number and were
double-blinded to the investigators as well as the participants.
The serial numbers corresponding to the individual supplements
were kept blind to the staff until the conclusion of the study.
Participants were instructed to consume two servings per day
of their respective supplement. On training days, one serving
was consumed immediately following resistance exercise, and the
other serving was consumed prior to bed. On non-training days,
one serving was consumed between meals, and the other serving
was consumed prior to bed. Supplements were mixed in shaker
bottles with 500 mL of water, and participants were instructed
as to how to blend their supplement. Individual packets were
distributed in a 3-week supply, and empty packets were returned
to ensure compliance. Participants that did not consume 80% or
more of packets were excluded from analyses.
Food logs were filled out by participants at baseline (PRE)
and week 12 (POST) of training. Participants were given
detailed instructions on how to determine food proportions
and thoroughness of meal description needed for accurate
assessment. Four daily food records (2 weekdays [Mon–Fri]

Skeletal Muscle Biopsy
Skeletal muscle biopsy procedures have been described by
our laboratory elsewhere (40, 41). Briefly, participants were
instructed to lay supine on a treatment table. Excision of vastus
lateralis tissue using a 5 mm Bergstrom Biopsy needle with
suction was performed using local anesthesia (1% Xylocaine)
and aseptic technique. Tissue was immediately blotted and
then distributed for immunohistochemistry (IHC) and molecular
analyses. The IHC section was placed in a cryomold with
optimal cutting temperature (OCT) media (Electron Microscopy
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Santa Cruz Biotechnology, sc-514037), BCAT2 (1:1,000; Abcam,
ab95967), BCKDHα (1:1,000; Genetex, GTX45109, Irvine, CA,
USA), eGFP (1:1,000; Bioss Inc.; bs-2194R, Boston, MA, USA),
and Puromycin (1:1,000; MilliporeSigma; MABE342; Burlington,
MA, USA). Primary antibody was incubated with membranes
overnight at 4◦ C in TBST with 5% bovine serum albumin (BSA).
The following day, membranes were incubated with horseradish
peroxidase-conjugated anti-rabbit or anti-mouse IgG (1:2,000,
Cell Signaling) in TBST with 5% BSA at room temperature for
1 h. Membrane development was performed using an enhanced
chemiluminescent reagent (Luminata Forte HRP substrate;
MilliporeSigma). Band densitometry was performed using a gel
documentation system and associated densitometry software
(UVP, Upland, CA, USA). Densitometry values for all protein
targets were normalized to Ponceau S densities. Each participant’s
PRE and POST sample was run in continuous lanes and on the
same gel. All values for a given protein target were normalized to
each participant’s PRE value to provide fold change scores.
Notably, membranes for various targets were cut into upper
and lower sections for antibody incubations; for example, one
set of membranes were cut in half ∼55 kDa and the top half
membrane was incubated with ATF4 primary antibody solution
(target band ∼63 kDa), whereas the bottom half membrane was
incubated with LAT1 primary antibody solution (target band
∼48 kDa). Additionally, bottom half membranes were re-probed
for BCKDHα by exposing them to commercial stripping buffer
following LAT1 quantification (ThermoFisher Scientific; 21059),
and we ensured the stripping buffer removed all visible LAT1
bands prior to reprobing for BCKDHα. In these situations, the
same Ponceau images were used to normalize ATF4, LAT1, and
BCKDHα data (this can be seen in Figures 2A,B,F where the
same subjects were used for representative images).

and 2 weekend days [Sat and Sun]) were submitted by each
subject at both PRE and POST. Dietary intake was analyzed
using “MyFitnessPal” (MyFitnessPal, Inc., Baltimore, MD, USA).
Participants were instructed to not add supplementation to their
food logs. Upon completion of the study, supplement nutrition
was added to existing totals and then averaged to represent
participants’ eating habits.

Resistance Training Program
Strength testing was completed at PRE whereby participants
performed a 3-repetition maximum for squat and bench
press. Following PRE testing, participants completed 12 weeks
of resistance exercise training prescribed 3x/week. Exercises
included squat, bench press, deadlift, and bent-over row
prescribed at 4 sets of 10 repetitions on Sunday or Monday, 6
sets of 4 repetitions on Tuesday or Wednesday, and 5 sets of 6
repetitions on Thursday or Friday. Relative training intensities
were based on PRE testing 3-repetition maximum values and
increased weekly with the exception of 2 weeks (weeks 7 and
12) which were dedicated for “deloading” (i.e., a reduction in
training volume) to prevent injury and promote recovery. More
information regarding progression through the training period
can be found within Mobley et al. (39). Participants who missed
more than 4 exercise sessions were not included in analyses
due to lack of training compliance. POST strength testing was
performed following 12 weeks of resistance exercise training
whereby participants performed a 3-repetition maximum for
squat and bench press.

Western Blot Analysis
For protein analyses, ∼50 mg from each muscle biopsy sample
was placed in 1.7 mL microcentrifuge tubes containing 500 µL
of ice-cold cell lysis buffer [20 mM Tris-HCl (pH 7.5), 150 mM
NaCl, 1 mM Na2 EDTA, 1 mM EGTA, 1% Triton; Cell Signaling,
Danvers, MA, USA] pre-stocked with protease and Tyr/Ser/Thr
phosphatase inhibitors (2.5 mM sodium pyrophosphate, 1 mM βglycerophosphate, 1 mM Na3 VO4 , 1 µg/mL leupeptin). Samples
were then homogenized by hand via micropestle manipulation,
insoluble proteins were removed with centrifugation at 500
g for 5 min and obtained sample lysates were batch processassayed for total protein content using a BCA Protein Assay
Kit (Thermo Fisher Scientific). Lysates were then prepared for
Western blotting using 4x Laemmli buffer and standardized for
protein content at 1.0 µg/µL. Samples were equally loaded onto
10% SDS-polyacrylamide gels (Bio-Rad, Hercules, CA, USA)
and subjected to electrophoresis (150 V for 60 min) using premade 1x SDS-PAGE running buffer (Ameresco). Proteins were
then transferred (200 mA for 2 h) to polyvinylidene difluoride
membranes (Bio-Rad), Ponceau S stained, and imaged to ensure
equal protein loading between lanes. Membranes were then
blocked for 1 h at room temperature with 5% non-fat milk
powder in Tris-buffered saline with 0.1% Tween-20 (TBST;
Ameresco, Solon, OH, USA). Following blocking, membranes
were incubated in primary antibodies including: ATF4 (1:2,000;
Abcam, ab1371, Cambridge, MA, USA), LAT1 (1:1,000; Cell
Signaling, #5347, Danvers, MA, USA), PAT1 (1:200; Santa Cruz
Biotechnology, sc-368553, Dallas, TX, USA), SNAT2 (1:1,000;
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Immunohistochemical Analysis
Immunohistochemistry (IHC) was performed to determine
muscle fiber cross-sectional area (fCSA) and LAT1 protein
content, and these procedures have been previously described
(42). Briefly, skeletal muscle biopsy samples frozen in OCT media
were sectioned to 10 µm using a cryotome (Leica, Biosystems;
Buffalo Grove, IL, USA). All samples were sectioned and stored
at −80◦ C until staining occurred. To determine fCSA, sections
were air-dried at room temperature for 30 min, fixed with
10% formalin for 10 min, permeabilized in phosphate-buffered
saline (PBS) that contained 0.5% Triton X-100, and blocked
with 100% Pierce Super Blocker (ThermoFisher Scientific;
#37515) for 25 min. Sections were then washed with PBS and
incubated for 1 h in primary antibody solution containing
rabbit anti-dystrophin (ThermoFisher Scientific; PA5-32388) at
1:100 dilution and mouse anti-myosin II (Hybridoma Bank;
SC71) at 1:100 dilution in blocking solution. Sections were
then washed for 5 min in PBS and incubated with secondary
antibody solution containing Texas Red anti-rabbit (Vector
Laboratories; Burlingame, CA, USA) at 1:100 dilution and Alexa
Flour 488 anti-mouse (ThermoFisher Scientific) at 1:100 dilution
in blocking solution. Notably, it was possible to capture fibertype distribution using this technique. As a result, the “mean
fCSA” metric used as a dependent measure herein is the change
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in fiber cross sectional area relative to that individual’s fiber type
distribution. Alternatively stated, the change in Type I fibers was
made relative to the participant’s respective fiber type distribution
and was then added to the change in Type II fibers relative to the
respective fiber type distribution for a “mean fCSA.”
To determine LAT1 protein content, methods from Hodson
et al. (43) were utilized with the exception of the fixation step
as this step was found to confound the LAT1 signal during
pilot staining. This alteration may explain the difference in
staining intensity between their investigation and the present
investigation. Briefly, sections were air-dried for 10 min, washed
3 times in PBS for 5 min each, and then blocked using
Superblocker (ThermoFisher Scientific; #37515) for 30 min.
Sections were then incubated with primary antibody solution
containing mouse anti-dystrophin (ThermoFisher Scientific;
PA5-32388) at 1:100 dilution and rabbit anti-LAT1 (Abcam,
#85226) at 1:100 dilution (43). Notably, these experiments were
duplicated with the same LAT1 primary antibody used during
western blotting (Cell Signaling, #5347); however, this antibody
was not specifically designated for IHC per manufacturer
recommendations. As a result, only data yielded from the
working antibody (Abcam, #85226) are presented herein.
Sections were incubated in primary antibody solution for 2 h,
washed in PBS, and incubated for 1 h with secondary antibody
containing Texas Red anti-rabbit (Vector Laboratories; TI-1000)
and Alexa Fluor 488 anti-mouse (Thermo Fisher Scientific; A11001). Sections were then washed with PBS, mounted, and
stored in the dark at 4◦ C until fluorescent images were taken.
Notably, preliminary experimentation determined the antibodies
used did not display cross-reactivity.
Digital 20x and 40x images were obtained using a fluorescence
microscope (Nikon Instruments; Melville, NY, USA). Four
sections (3 experimental and 1 negative control) per participant
were mounted on each slide. Each section was separated by
∼100 µm. Two images were taken per experimental section
for a total of 6 images per participant per timepoint, and at
least 50 fibers were quantified per image. The counts from the
6 images were averaged and used during statistical analysis.
Approximate exposure times were 600 ms for red and green
imaging. This staining method allowed the identification of
cell membranes (detected by the FITC filter; green) and LAT1
protein (detected by the TRITC filter; red). Measurements for
type I fCSA, type II fCSA, and mean fCSA and LAT1 protein
were conducted using the open-sourced software CellProfilerTM
(44) whereby the number of pixels counted within the border
of each muscle fiber were converted to total area. Threshold
settings for quantifying LAT1 protein were first validated by
manually counting the number of LAT1 protein particles, and
then adjusting the threshold settings to meet the manually
counted LAT1 protein particles.

myotubes without a virus. Cells were seeded in 6-well plates
(Corning; #3335) at 0.3 x 106 in 3 mL of growth medium per well.
Once myoblasts reached 60–70% confluence, myoblasts were
transfected with a LAT1 plasmid (Genecopoeia, Rockville, MD,
USA; EX-Mm05301-M98) via Lipofectamine 2000 (Invitrogen;
#11668019) using manufacturer’s protocols. Control cells were
transfected with an empty vector (Genecopoeia, EX-NEGM98) using identical methods. Both plasmids utilized a CMV
promoter within the pReceiver-M98 vector and contained an
eGFP reporter. Twenty-four hours later cells were pulse-labeled
with 1 µM puromycin hydrochloride (Ameresco) in PBS to assess
relative protein synthesis levels. Puromycin was incubated with
cells for 30 min, medium was removed, cells were washed with
ice-cold PBS, and harvested in ice-cold cell lysis buffer that
was previously described. Western blotting methods for cell
culture samples was identical to methods previously described.
Proteasome activity assays on cell lysates were completed
using a commercially available fluorometric kit according to
manufacturer’s instructions (MilliporeSigma; APT280).

Cell Culture

Statistical Analyses

C2C12 myoblasts, passage number 5–8, were maintained in
Dulbecco’s Modified Eagle Medium (DMEM; Gibco; #11965092)
supplemented with 10% Fetal Bovine Serum (FBS), 1% penicillinstreptomycin, and 0.1% gentamycin. Myoblasts were used instead
of myotubes given the well-known difficulty in transfecting

Certain data (e.g., participant characteristics, muscle fCSA,
nutrition information) have been previously analyzed with
additional supplementation groups, different sample sizes, and
different statistical methods (39); however, these data have been
reanalyzed herein using the three groups of interest, sample sizes

Frontiers in Nutrition | www.frontiersin.org

Liquid Chromatography-Mass
Spectrometry
Intracellular amino acid concentrations from C2C12 myoblasts
were determined by using a liquid chromatography–electrospray
ionization–mass spectrometry system (QTrap 5500 MS; AB
Sciex; Framingham, MA, USA) with liquid chromatography
device ExpressHT Ultra LC (Eksigent Div; AB Sciex). Samples
were standardized with 0.1 N HCl that contained a stable
isotopomer of every amino acid as an internal standard.
Samples were transfer pipetted onto strong-cation-exchange drip
columns. Columns were washed with water and eluted with
2.5 mol/L ammonia. Eluates were desolvated in a centrifugal
evaporator. Solid-residue tubes were capped for storage in the
dark at room temperature. Within 3 d of liquid chromatography–
electrospray ionization–mass spectrometry analysis, samples
were derivatized with 9-fluorenylmethoxycarbonyl (FMOC)
and subsequently neutralized, after which sample solutions
were injected onto a 0.5 × 100 mm HALO C18 column
(Eksigent Div; AB Sciex) and kept at 35◦ C. Analytes were
eluted with a segmentally linear gradient from 35 to 85%
acetonitrile in water supplemented with ammonium acetate to
10 mmol/L and 5% isopropanol. Detection was performed by
using electrospray triplequadrupole–tandem mass spectrometry
in multiple-reaction monitoring mode. FMOC amino acid
derivatives were fragmented in the collision cell for detection of
either free aminoacyl anions or a fragment larger by 26 atom mass
units (coming from the FMOC derivative), whichever gave the
highest sensitivity. Thus, monitoring occurred for each amino
acid, and internal standards. We used the SignalFinder algorithm
in MultiQuant software (version 2.1; ABScieix) to quantify peaks.
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TABLE 2 | Participant characteristics prior to and following resistance training.
PLA (n = 12)
PRE

POST

LEU (n = 13–14)
PRE

POST

WPC (n = 15–17)
PRE

ANOVA p-value

POST

Group

Age (years)

21 ± 1

20 ± 1

21 ± 2

0.336

Height (cm)

182.2 ± 9.1

179.4 ± 4.8

179.0 ± 6.4

0.444

3,07,020 ± 34,937

3,24,637 ± 60,633

3,30,086 ± 51,791

0.414

Total volume lifted (kg)

Time

G×T

Fat mass (kg)

17.4 ± 4.9

17.8 ± 4.7

15.3 ± 5.8

15.8 ± 6.4

19.5 ± 8.6

18.7 ± 8.3

0.366

0.930

0.120

Fat free mass (kg)

57.3 ± 6.5

60.2 ± 6.4

56.8 ± 5.1

59.3 ± 4.9

59.0 ± 7.0

61.3 ± 6.9

0.625

<0.001

0.664

Total mass (kg)

74.8 ± 10.0

78.0 ± 9.5

72.1 ± 9.5

75.1 ± 10.3

78.5 ± 13.0

80.0 ± 13.4

0.387

<0.001

0.212

VL thickness (cm)

2.28 ± 0.30

2.74 ± 0.32

2.41 ± 0.24

2.77 ± 0.30

2.49 ± 0.23

2.96 ± 0.29

0.080

<0.001

0.446

67 ± 12a

108 ± 15*

85 ± 20b

112 ± 22*

83 ± 21b

118 ± 23*

0.177

<0.001

0.031

3RM–Squat (kg)

* <0.050 compared to PRE within group only if the G × T interaction was significant.
Differing letters represent significant differences between groups within each time point. Bold lettering denotes a significant p-value.

analysis, heteroscedasticity, and residuals were analyzed. Sample
sizes are noted in each figure legend and vary due to tissue and
sample limitations. All data are presented as mean ± standard
deviation values, trending statistical significance was established
as 0.050 < p < 0.100, and statistical significance was established
as p < 0.050. All statistical analyses were performed using SPSS
version 24.0 (Chicago, IL, USA).

related to this investigation, and alternate statistical methods
which are described below.
Various participant characteristics were compared between
groups using one-way ANOVAs. All dependent variables related
to IHC, Western blotting, certain participant characteristics,
and nutritional data were assessed using two-way repeated
measures ANOVAs to test differences between groups (PLA,
WPC, and LEU) and over time (PRE and POST). Fold-change
was utilized for protein expression and IHC whereby POST
was divided by PRE within each participant. This method was
chosen based on past literature (18–20). Fold changes from
all participants in a given group were then averaged. Given
PRE was normalized to 1 with no standard deviation, the main
effect for group p-value and group by time interaction p-value
were identical; therefore, only the main effect for group and
the main effect for time p-values were reported. Unlike this
investigation, the aforementioned studies utilized 3 or more
time points which allowed for numerical differences between
the group main effect and group by time interaction p-values.
Again, this method was chosen a priori based on the previous
literature. Pearson correlations were also performed between all
participant’s individual change in fCSA and their fold change
in western blot proteins to determine if relationships existed
between these variables and, if trending toward significance or
significant, was followed up with a simple linear regression
analysis for each group to discern potential group differences.
Cell culture data were analyzed using independent samples ttests between conditions (LAT1 overexpression or control). Cell
culture data fold change values were generated by dividing each
sample value by the CTL average.
Normality was tested for all dependent variables using a
Shapiro-Wilk test. Outliers were removed if they were ±3 times
the interquartile range. When appropriate, Levene’s test for
equality of variances was determined. Assumptions testing was
seldom violated; however, data were not manipulated due to the
robustness of the ANOVA test, and the majority of the groups
within the analysis did not violate this assumption. If a significant
f-value was found following an ANOVA test, further statistical
analysis was conducted using a LSD post-hoc comparison given
the exploratory nature of this investigation. For regression
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RESULTS
Participant Characteristics and Nutrition
Information
Participant characteristics are reported in Table 2. As noted in
the parent publication by Mobley et al. (39), 18 participants were
enrolled in the PLA group, and 15 participants finished the study
due to supplement and workout compliance. The LEU group had
17 initial enrollees, and 15 participants finished the study due to
supplement and workout compliance. The WPC group had 19
initial enrollees, and 17 participants finished the study due to
supplement and workout compliance. Due to tissue limitations,
however, samples sizes are reported in each figure legend.
Notably, differences did not exist between groups for age,
height, or total volume lifted (p > 0.050). Moreover, fat mass,
fat free mass, total mass, or vastus lateralis (VL) thickness were
not different between groups at the beginning of the study (p
> 0.050). Fat free mass, total mass, and VL thickness increased
following resistance training (p < 0.001). Performance measured
by squat demonstrated a group by time interaction (p = 0.031)
whereby PLA squatted less than LEU and WPC at PRE; however,
no differences existed at POST. All groups increased squat
performance from PRE to POST (p < 0.001).
Self-reported nutrient intake data are reported in Table 3. All
groups increased nutrient intake shown by a significant time
effect for consumption of absolute and relative carbohydrates,
protein, fat, and total energy following training (p < 0.005). WPC
consumed less absolute and relative carbohydrates (p < 0.050)
and more absolute and relative protein (p < 0.050) compared
to PLA and LEU; albeit, all groups consumed statistically similar
amounts of absolute and relative total energy.
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TABLE 3 | Nutrition information prior to and following resistance training.
PLA (n = 12)

LEU (n = 14)

PRE

POST

Carbohydrates (g)

225 ± 92

348 ± 123*a

206 ± 62

Carbohydrates (g/kg)

2.9 ± 1.1

4.3 ± 1.3*a

2.8 ± 1.1

Protein (g)

80 ± 20

112 ± 49*a

87 ± 24

Protein (g/kg)

1.1 ± 0.2

1.4 ± 0.5a

1.2 ± 0.3

Fat (g)

78 ± 21

111 ± 52

73 ± 18

92 ± 24

Fat (g/kg)

1.0 ± 0.3

1.4 ± 0.5

1.0 ± 0.3

1.2 ± 0.4

1,969 ± 631

2,830 ± 1,006

1,835 ± 435

2,488 ± 495

25.4 ± 7.7

34.8 ± 10.1

24.9 ± 7.3

32.6 ± 8.7

Total energy (kcal)
Total energy (kcal/kg)

PRE

WPC (n = 17)

POST

ANOVA p-value

PRE

POST

Group

Time

G×T

310 ± 79*a

215 ± 59

244 ± 64b

0.100

<0.001

0.009

4.1 ± 1.4*a

2.8 ± 1.0

3.0 ± 1.0b

0.143

<0.001

0.010

108 ± 36*a

88 ± 26

145 ± 24*b

0.094

<0.001

0.009

1.4 ± 0.5a

1.1 ± 0.3

1.8 ± 0.4b

0.294

<0.001

0.009

71 ± 22

93 ± 51

0.354

0.002

0.744

0.9 ± 0.4

1.2 ± 0.7

0.480

0.005

0.851

1,866 ± 475

2,389 ± 729

0.347

<0.001

0.519

23.7 ± 8.1

29.6 ± 11.0

0.454

<0.001

0.631

* <0.050 compared to PRE within group only if the G × T interaction was significant.
Differing letters represent significant differences between groups within each time point. Bold lettering denotes a significant p-value.

Fiber Cross Sectional Area
Following 12 weeks of total-body resistance exercise training,
type I fibers increased in fiber cross-sectional area (fCSA) from
3,618 ± 919 µm2 to 4,052 ± 982 µm2 which was demonstrated
by a significant time effect (p = 0.002; Figure 1A). Likewise,
Type II fibers increased in fCSA following training from 4,648
± 1,170 µm2 to 5,661 ± 1,768 µm2 shown by a significant time
effect (p < 0.001; Figure 1B). Lastly, growth of Type I and II
fibers relative to each participant’s fiber type composition (mean
fCSA) increased following training from 4,297 ± 932 µm2 to
5,063 ± 1,292 µm2 demonstrated by a significant time effect
(p < 0.001; Figure 1C). Neither type I, type II, or mean fCSA
revealed a group effect (p > 0.050) or group x time interaction
(p > 0.050).

Protein Abundance
ATF4 protein (Figure 2A) demonstrated a group effect (p =
0.030) whereby the fold change in PLA (0.77 ± 0.09) was less
than LEU (1.04 ± 0.29; p = 0.011), but not different than WPC
(0.87 ± 0.27; p = 0.308), although WPC trended to be lower
than LEU (p = 0.061). ATF4 protein decreased following training
which was demonstrated by a significant time effect (p = 0.029;
1.00 to 0.91); albeit, only PLA significantly decreased from PRE to
POST (1.00 to 0.77 ± 0.09) while LEU and WPC were unaltered
(p > 0.050).
LAT1 protein (Figure 2B) revealed a group effect (p = 0.043)
whereby the fold change in PLA (5.01 ± 5.50) was higher than
LEU (1.87 ± 1.49; p = 0.023) and WPC (2.15 ± 2.43; p = 0.031),
but LEU and WPC were not significantly different from one
another. LAT1 protein also increased following training which
was demonstrated by a significant time effect (p = 0.001; 1.00
to 2.86). PLA (1.00 to 5.01 ± 5.50) and LEU (1.00 to 1.87 ±
1.49) significantly increased from PRE to POST while WPC was
unaltered (p > 0.050).
SNAT2 protein (Figure 2C) was unaltered following training
or by supplementation shown by a non-significant group effect
(p = 0.399) and time effect (p = 0.216). Similarly, BCAT2
protein (Figure 2E) was unaltered by training (time p = 0.170) or
supplementation (group p = 0.808). PAT1 protein (Figure 2D)
increased with training shown by a significant time effect (p =
0.040; 1.00 to 1.37) but not with supplementation shown by a
non-significant group effect (p = 0.993).
Frontiers in Nutrition | www.frontiersin.org

FIGURE 1 | Muscle fiber cross-sectional area (fCSA) increases with resistance
exercise training independent of supplementation group. Skeletal muscle type
I (A), type II (B), and mean (C) fCSA increased following 12 weeks of
total-body resistance exercise training independent of consuming placebo
(PLA), leucine (LEU), or whey protein concentrate (WPC). Open columns
designate pre-training values (PRE), and closed columns designate
post-training values (POST). Data are represented as mean ± standard
deviation. Sample size for each group is PLA = 12, LEU = 13, and WPC = 15.

BCKDHα protein (Figure 2F) demonstrated a group effect
(p = 0.044) whereby the fold change in PLA (2.35 ± 1.36) was
greater than LEU (1.44 ± 0.88; p = 0.035) and WPC (1.38 ± 0.95;
7
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FIGURE 2 | The protein content of amino acid transporters and metabolic enzymes are altered following 12 weeks of resistance exercise training. The fold change
from PRE, designated as the dashed line at 1.00, for ATF4 (A), LAT1 (B), SNAT2 (C), PAT1 (D), BCAT2 (E), and BCKDHα (F) protein content for each group. A
representative image for each protein and loading control (i.e., Ponceau S stain) accompanies each panel. Differing letters represent significant differences between
groups within each time point. *p < 0.050 compared to PRE within group only if the G × T interaction was significant. Data are represented as mean ± standard
deviation. Sample size for each group is PLA = 10–12, LEU = 13–14, and WPC = 16–17.

Using the appropriate antibody (Abcam, #85226), staining
for total LAT1 protein (sarcoplasmic and membrane LAT1;
Figure 3A), membrane LAT1 protein (Figure 3C), or membrane
LAT1/fiber (Figure 3D) did not reveal a group effect (p > 0.050)
or time effect (p > 0.050). Total LAT1/fiber did not demonstrate a
group effect (p = 0.599) but did show a time effect whereby Total
LAT1/fiber increased from PRE to POST (p = 0.003; 1.00 to 1.09
± 0.14; Figure 3B).

p = 0.022), but LEU and WPC were not significantly different
from each other. BCKDHα protein also increased following
training which was demonstrated by a significant time effect (p
< 0.001; 1.00 to 1.78), although only PLA significantly increased
from PRE to POST (1.00 to 2.35 ± 1.36) while LEU and WPC
were unaltered (p > 0.050).

Immunohistochemistry
To confirm our LAT1 western blot data, IHC for LAT1 was
performed. Two separate antibodies for LAT1 (Abcam, #85226;
Cell Signaling, #5347) were used and analyzed identically but did
not produce congruent results. In fact, no correlation existed for
the same metric between the two different antibodies (p > 0.050)
(data not shown). In this regard, one antibody (Abcam, #85226)
was designated for immunohistochemistry per manufacturer’s
recommendations and is presented herein (Figure 3), while the
other antibody was not designated for immunohistochemistry
(Cell Signaling, #5347). Results from this antibody (Cell
Signaling, #5347) are shown in Supplementary Figure 1. Using
the same dependent metrics for immunohistochemistry listed
below, there were no significant findings using this antibody (Cell
Signaling, #5347) (p > 0.050).

Frontiers in Nutrition | www.frontiersin.org

Correlations and Regression
To determine if the change in amino acid transporters or
metabolic enzymes was indicative of hypertrophy a correlation
table was created and is shown in Table 4. Notably, changes in
measured proteins were not indicative of the change in Type I
fCSA, Type II fCSA, or mean fCSA; however, the change in ATF4
protein trended toward a significant (0.050 < p < 0.010) weak
correlation (r = 0.287–0.314) for changes in measures of fCSA.
Moreover, PRE raw-value protein content for each measured
protein was not correlated with the change in Type I fCSA, Type
II fCSA, or mean fCSA (p > 0.100) (data not shown).
To delineate if the trending correlation between the change in
ATF4 protein content and the change in fCSA was skewed by a
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FIGURE 3 | LAT1 protein increases per skeletal muscle fiber with resistance exercise training but the increase in protein is not located on the membrane. The fold
change from PRE, designated as the dashed line at 1.00, for Total LAT1 (A), Total LAT1 per fiber (B), Membrane LAT1 (C), and Membrane LAT1 per fiber (D) protein
content for each group using immunohistochemistry. A representative image showing green-stained dystrophin and red-stained LAT1 protein using 20x magnification
(E); the inset in E is magnified using 40x magnification (F) and the arrows point toward LAT1 protein. The scale bar in both images is 100 µm. *A significant effect.
Data are represented as mean ± standard deviation. Sample size for each group is PLA = 10, LEU = 9, and WPC = 9.

certain group, a simple linear regression analysis was performed
for each group. Indeed, when the change in ATF4 protein was
used to predict the change Type I fCSA, a significant (p = 0.035)
coefficient of determination (r2 = 0.344) was found for LEU
but not for PLA or WPC (Figure 4A). The change in Type II
fCSA was not significantly predicted when using the change in
ATF4 protein as the predictor (p = 0.079; Figure 4B). When the
change in ATF4 protein was used to predict the change in mean
fCSA, LEU demonstrated a significant (p = 0.043) coefficient of
determination (r2 = 0.322; Figure 4C).

TABLE 4 | Correlations for the change in fCSA and the fold change in proteins.
1 Type I fCSA

1 Mean fCSA

r-value

p-value

r-value

p-value

r-value

p-value

−0.079

0.627

−0.163

0.313

−0.165

0.309

0.023

0.891

0.167

0.316

0.104

0.533

1 PAT1

−0.066

0.690

−0.068

0.681

−0.065

0.692

1 ATF4

0.287

0.081

0.305

0.063

0.314

0.055

1 BCAT2

0.164

0.331

0.199

0.238

0.160

0.343

1 BCKDHA

0.021

0.899

−0.043

0.796

−0.071

0.667

1 LAT1
1 SNAT2

Sample size for each correlation was 37–40.

Cell Culture
LAT1 protein was overexpressed (OvEX) in C2C12 myoblasts
compared to controls (CTL) (p = 0.026; Figure 5A). Given
the plasmid construct contained eGFP, this protein was also
quantified using western blotting and was not different between
CTL and OvEX (p = 0.977) suggesting transfection efficiency
was equal between groups (data not shown). BCKDHα protein
decreased with LAT1 protein overexpression compared to CTL
(p = 0.001; Figure 5B). Using LCMS to determine amino acid
concentrations within cell lysates, LAT1 protein overexpression
did not alter the concentration of Thr, Val, Met, Ile, Leu, Phe, His,
Lys, total BCAAs, or total EAAs (Figure 5C). Protein synthesis
measured by puromycin incorporation was lower when LAT1
protein was overexpressed (p = 0.002; Figure 5E); however,
proteasome activity was not altered (p = 0.347; Figure 5D).

Frontiers in Nutrition | www.frontiersin.org

1 Type II fCSA

DISCUSSION
Resistance exercise training is a potent anabolic stimulus
for promoting skeletal muscle growth and when paired with
protein or amino acid supplementation, skeletal muscle growth
is optimized (39, 45). Both resistance exercise and protein
supplementation independently, and in concert, alter skeletal
muscle amino acid transporters and enzymes involved with
amino acid metabolism (29, 38). The current investigation
demonstrates that amino acid transporters and enzymes involved
with BCAA metabolism are altered following 12 weeks of
total-body resistance exercise training. Our in vitro findings
demonstrate that perturbations in LAT1 protein levels can
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FIGURE 4 | The change in ATF4 protein predicts the change in fCSA only in LEU following 12 weeks of resistance exercise training. Regression analysis was
completed using the change in ATF4 protein to predict the change in Type I (A), Type II (B), and mean (C) fCSA. Each panel contains each group’s predictive equation,
coefficient of determination (r 2 ), and p-value. Best fit lines are displayed in each graph. *A significant prediction. Sample size for each group is PLA = 12, LEU = 13,
and WPC = 15.

lead to appreciable alterations in protein synthesis and amino
acid metabolism.
Each group utilized in the present study consumed a
unique supplement and, as expected, PLA and LEU ingested
more carbohydrates, but less protein, than WPC. Importantly,
absolute and relative total energy consumption was not different
between groups given increased energy consumption provides
more energy to meet metabolic demand or energy-intensive
processes such as protein synthesis. Furthermore, the total
amount of weight lifted (i.e., training volume) was not different
between groups. Even though supplementation was different
between groups, all groups equally increased muscle strength and
hypertrophy which was measured by 3-RM squat and ultrasound,
respectively. Furthermore, all groups equally increased type I,
type II, and mean fCSA with training. Taken together, these
results suggest the differences in molecular markers are specific
to the supplementation provided.
Several studies have demonstrated skeletal muscle LAT1
protein levels acutely increase following amino acid ingestion,
resistance exercise, or both together (18, 19, 38). LAT1 protein
is also influenced by bed rest as 7 d of bed rest attenuated the
increase in LAT1 protein compared to control (20). The acute
increase in amino acid transporters in response to resistance
exercise appears transient given that LAT1 protein is not different
72 h following 3 bouts of endurance or resistance exercise
compared to basal levels (37) suggesting the findings herein
are a resistance exercise training effect. Following 12 weeks
of resistance exercise training, LAT1 protein increased and,
unexpectedly, increased the most in PLA. This unexpected result
may be a result of the significant downregulation of ATF4 protein
in the PLA group. These findings regarding the ATF4 protein
data expand and corroborate prior literature. First, ATF4
expression is upregulated during periods of amino acid or energy
deficiency such as exercise (24). In this regard, Drummond et al.
found an increase in ATF4 protein following resistance exercise
(19); however, an unexpected and similar increase in ATF4
protein has also been observed following amino acid ingestion
(18). Second, ATF4 has been implicated in promoting muscle
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atrophy (22, 24) and, therefore, a reduction in ATF4 protein
content would promote hypertrophy, which is corroborated
herein by the significant reduction in ATF4 protein seen in PLA.
It is plausible to suspect an initial increase in ATF4 protein during
the first weeks of training promoted an increase in LAT1 protein
(as well as PAT1 protein); however, as training progressed,
ATF4 protein content may have become downregulated from the
improved transport capacity of amino acids.
Although other leucine transporters exist (e.g., LAT4), LAT1
is suggested to be most important for leucine transport, and
it is essential for LAT1 to reside on the cellular membrane
to fulfill transport (46, 47). This study extends the findings
of Hodson et al. (43) who optimized a procedure for LAT1
IHC, and found LAT1 protein was greater in Type II muscle
fibers. The present investigation found total LAT1 protein per
fiber increased equally in all groups with training, which partly
agrees with the western blot data. Total LAT1 protein was
unaltered following training, which is likely due to the increased
fCSA and less countable fibers in the field of view as well as
the sensitivity differences between IHC and western blotting.
Interestingly, we did not find LAT1 protein to increase along
the sarcolemma following training. This notion suggests LAT1
may be internalized within the cell and translocated to the
sarcolemma acutely in response to an anabolic stimulus similar
to how LAT1 can be recruited to the lysosomal membrane (48).
Moreover, Hyde et al. suggests internalization of SNAT2 with
ceramide treatment (49) which suggests amino acid transporters
have altered subcellular distribution following a given stimulus.
Under basal conditions, LAT1 may be internalized and shuttled
to the sarcolemma in response to resistance training or amino
acid ingestion, although this is speculation.
To better understand if any of the molecular targets were
related to changes in muscle fCSA, a simple linear regression
analysis was performed. Following a correlation analysis, it
was determined the change in ATF4 protein, albeit trending
significance, was the only plausible candidate from measured
markers to predict the change in muscle fCSA. Intriguingly,
a relationship existed for LEU, but not PLA and WPC, and
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FIGURE 5 | LAT1 protein overexpression in C2C12 myoblasts decreases protein synthesis. Overexpression of LAT1 protein (OvEX) increases LAT1 protein (A) but
decreases BCKDHα protein (B) compared to control (CTL). Amino acid concentrations from whole cell lysates (C) as well as proteasome activity (D) were unaltered by
LAT1 protein overexpression. Puromycin incorporation, a surrogate for protein synthesis, decreased following LAT1 overexpression (E). Representative images for
each measured protein accompany each panel. In panel C open columns represent CTL and closed columns represent OvEX. *p < 0.050 compared to control.
Sample sizes for each treatment group was CTL = 11–12 and OvEX = 12 with the exception of (C) as each group’s sample size was 8.

the significant regression equations were positive suggesting
an increase in ATF4 protein was associated with skeletal
muscle fiber hypertrophy. These findings are in direct conflict
with previous literature suggesting ATF4 promotes muscle
atrophy (22–24); however, it is paramount to note these
findings are only respective to the changes seen following
12 weeks of resistance exercise training and do not reflect
acute alterations and the ensuing responses that could have
occurred during training. Importantly, the downregulation
found in ATF4 protein following resistance exercise training
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supports that an attenuation in ATF4 protein promotes skeletal
muscle hypertrophy, but the regression analysis suggests that
acute alterations in ATF4 protein may be more important for
determining skeletal muscle hypertrophy seen with exercise
training. As noted, the change in ATF4 protein only predicted
the change in muscle fCSA in the LEU group suggesting a
unique relationship may exist between ATF4 protein and leucine
supplementation. Moreover, it is possible the absence of the
other BCAAs or amino acids in the presence of high leucine
concentrations is causing this effect. Future investigations are
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increased LAT1 protein may promote greater efflux of amino
acids from the sarcoplasm effectively lowering intracellular
concentration and, perhaps, protein synthesis (48, 56). It is
also possible the production of the BCKDH complex subunits
turnover more slowly than transport proteins leading to a
buildup of alpha-ketoacids which are toxic in excess. It is
important to note these hypotheses are speculative and underpin
the need for more research in this area.
In conclusion, the current investigation demonstrates totalbody resistance exercise over 12 weeks affects amino acid
metabolism and transporter content. While acute exercise was
known to affect amino acid transporters, these data provide
context to long-term adaptations in amino acid transporters
in response to chronic resistance exercise. Indeed, resistance
exercise training increases skeletal muscle LAT1, PAT1, and
BCKDHα protein and decreases ATF4 protein. These markers
are also affected by nutritional supplementation during training
as shown by PLA participants experiencing the most pronounced
alterations in these markers. The alterations in measured
proteins do not appear to be associated with regulating skeletal
muscle hypertrophy; however, regression analysis suggests
a unique relationship between ATF4 and leucine. Lastly,
overexpression of LAT1 protein decreased BCKDHα protein and
protein synthesis without altering amino acid concentrations or
proteasome activity, which suggests enzymes related to amino
acid metabolism may affect protein synthesis.

needed to determine the precise relationship of ATF4 and leucine
as well as other amino acids.
Amino acid metabolism, and specifically BCAA metabolism,
is foundational for anaplerotic reactions. These reactions serve
to meet metabolic demands while indirectly stimulating protein
synthesis by limiting oxidation of amino acids (e.g., leucine). In
spite of the fact that BCAT2 protein levels have been shown to
be involved with metabolism and endurance performance (50,
51), our results suggest resistance exercise training or different
supplementation paradigms do not impact this marker. The
BCKDH complex is critical for BCAA metabolism given that
it is the rate-limiting enzyme and is the commitment step
toward generation of ATP from BCAA catabolism. BCKDHα
protein levels increased with training herein, where a significantly
greater increase occurred in the PLA vs. the LEU and
WPC groups. The alpha-subunit of the complex is critical as
phosphorylation of this subunit by the BCKDH kinase inactivates
the complex (25). Unfortunately, due to limited resources and
tissue, this investigation was unable to explore the protein
content of other subunits of the BCKDH complex or associated
regulatory enzymes such as the BCKDH kinase. Similarly,
activity and phosphorylation of the BCKDH complex was also
not measured, and these are limitations herein and warrant
further investigation.
Given that resistance training was found to increase skeletal
muscle LAT1 protein levels, in vitro experiments were performed
to determine if LAT1 overexpression affected various molecular
outcomes associated with anabolism (e.g., muscle protein
synthesis and proteasome activity). While LAT1-tranfected
cells possessed more LAT1 protein, intracellular amino acid
concentrations (and leucine in particular) were not altered
in LAT1-transfected vs. control cells. As mentioned above,
this may be related to the lack of an anabolic stimulus
required to localize LAT1 to the sarcolemma. Notwithstanding, a
provocative and unexpected finding was that the LAT1-trasfected
cells experienced an attenuation in puromycin incorporation
suggesting rates of protein synthesis were lower. Notably, our
laboratory has also observed that when LAT1 protein was
knocked down in C2C12 myotubes, there was an increase
in protein synthesis [(52); unpublished observations]. These
findings are puzzling given the presumption that increased
LAT1 protein would lead to increased intracellular leucine
and, thus, increased protein synthesis. Interestingly, amino acid
concentration nor proteasome activity was different between
control and overexpression cells, but BCKDHα protein was
lower in LAT1 overexpressed cells compared to control. The
findings from cell culture in conjunction with the findings from
humans regarding the different alterations in the BCKDHα
protein suggests the BCKDH complex is not only important
for metabolism but also affects protein synthesis. Indeed,
dysregulation of the BCKDH complex results in maple syrup
urine disease and is also associated with skeletal muscle atrophy
(53, 54). Based on these findings, cellular transport of amino
acids appears secondary to amino acid metabolism or, perhaps,
overall metabolism given high glucose concentrations can limit
amino acid oxidation (55). In attempt to reconcile the findings in
this investigation in concert with findings from previous studies,
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